RWD3 Real-World Use of Biologics and Prescription Topical Medications in a Pediatric Psoriasis Population

A third of psoriasis (PsO) cases report onset during childhood, but few treatments are FDA-approved specifically for use in pediatric patients. The purpose of this analysis was to describe prescription topical and biologic treatment and percent body surface area (%BSA) in a real-world pediatric PsO population.

Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: A Swenson, P Kumparatana, H Friedler, K Starzyk, J Paulus Source Type: research